SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-012464
Filing Date
2011-03-04
Accepted
2011-03-04 16:38:39
Documents
8
Period of Report
2011-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-7284_18k.htm 8-K 57902
2 EX-1.1 a11-7284_1ex1d1.htm EX-1.1 139739
3 EX-4.1 a11-7284_1ex4d1.htm EX-4.1 110383
4 EX-5.1 a11-7284_1ex5d1.htm EX-5.1 18713
5 EX-10.1 a11-7284_1ex10d1.htm EX-10.1 196698
6 EX-99.1 a11-7284_1ex99d1.htm EX-99.1 15376
7 GRAPHIC g72841mmi001.jpg GRAPHIC 5368
8 GRAPHIC g72841kc01i001.jpg GRAPHIC 5721
  Complete submission text file 0001104659-11-012464.txt   555663
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 11665178
SIC: 2836 Biological Products, (No Diagnostic Substances)